Birdwatch Note Rating
2023-05-24 14:08:39 UTC - HELPFUL
Rated by Participant: 91CDA097F899BD289795FE432B80E2F82FE482F2CD7470BDB4C1C9EAADB5C2A6
Participant Details
Original Note:
Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO has updated its recommendation. WHO now suggests the use of Remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization. https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator
All Note Details